Components

STMicroelectronics Delivers New STM32L4 MCUs with On-Chip Digital Filter, Supported by Extended Development Ecosystem

STMicroelectronics has begun volume production of ultra-low-power STM32L45x microcontrollers (MCUs), supported by a development ecosystem based on the easy-to-use and affordable STM32Cube platform.

The STM32L451, STM32L452, and STM32L462 lines integrate a Digital Filter for Sigma-Delta Modulators (DFSDM), enabling advanced audio capabilities such as noise cancellation or sound localization on an inexpensive microcontroller. Up to 512 Kbyte on-chip Flash and 160 Kbyte SRAM provide generous code and data storage.

The new MCUs also feature a True Random-Number Generator (TRNG) that streamlines development of security-conscious applications such as connected smart devices. The STM32L462 further enhances support for developing secure devices by integrating an AES-256 cryptographic hardware accelerator.

Other features include smart analog peripherals such as a 12-bit 5Msample/s ADC, internal voltage reference, and ultra-low-power comparators. There are multiple timers, a motor-control channel, temperature sensor, a capacitive-sensing interface, and the STM32L452 also has a crystal-less USB2.0 controller.

The development ecosystem includes the STM32CubeMX initialization-code generator and STM32CubeL4 package comprising middleware components, Nucleo-64 Board-Support Package (BSP), Hardware Abstraction Layer (HAL), and Low-Layer APIs (LLAPIs). STM32CubeMX has a power-estimation wizard that assists low-power design and additional wizards for managing clock signals and pin assignments.

The Nucleo-64 board, NUCLEO-L452RE, provides an affordable and flexible way for users to try out new ideas and build prototypes. It integrates the ST-LINK/V2 probe-free debugger/programmer and can be expanded via Arduino®-compatible headers.

Offering features unavailable in other ultra-low-power MCUs, the new STM32L4 devices deliver both high core performance and outstanding ultra-low-power efficiency. The EEMBC®[1] CoreMark® score of 273 outperforms other ultra-low-power cores, while the ULPBench™ score of 245 confirms greater energy efficiency. Active-mode current of just 36µA/MHz enables longer runtime on small batteries and extends scope to create energy-neutral products powered from ambient sources.

Devices can be ordered now, in small-form-factor packages from QFN-48 to LQFP-100, including a 3.36mm x 3.66mm WLCSP. Prices start from $2.773 for the STM32L451CCU6 with 256 Kbytes Flash and 160 Kbytes SRAM in QFN-48, for orders of 10,000 pieces. Prices for development boards start at $14 for the legacy-compatible Nucleo-64 board (NUCLEO-L452RE), which is available now. The NUCLEO-L452RE-P board with external DC/DC converter will be available to distributors in June 2017.

Liat

Recent Posts

Tower Semiconductor Secures $1.3 Billion Silicon Photonics Agreements and Reports Strong Q1 2026 Growth

Tower Semiconductor announced that it has signed silicon photonics agreements valued at $1.3 billion for…

3 days ago

14 Israeli Cybersecurity Companies Named to the Rising in Cyber 2026 List of the World’s Most Promising Cyber Startups

The report is based on a survey of 150 CISOs and senior cybersecurity leaders from…

3 days ago

Sequent Selected by 15 Canadian Municipalities to Deliver Verifiable, Trust-Based Digital Voting for Elections

More than 200,000 voters will cast ballots using a secure and cryptographically verified online voting…

3 days ago

Sheba and Ichilov Medical Centers Join AccuLine’s International Clinical Trial for AI-Driven Early Heart Attack Risk Assessment

The multi-center study, involving 2,000 patients, will validate the CORA system - a breakthrough AI…

3 days ago

Molex Completes Acquisition of Teramount Ltd.

Molex, a global electronics leader and connectivity innovator, has completed the acquisition of Teramount Ltd.,…

6 days ago

Immunai Expands Oncology Collaboration, Extending AI-Driven Biomarker and Clinical Insights Through 2027

This agreement marks the third expansion of its collaboration with AstraZeneca, building on collaborations in…

6 days ago